Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study
- PMID: 15913794
- DOI: 10.1016/j.jneuroim.2005.03.016
Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study
Abstract
Substance P (SP) triggers responses in astrocytoma cells, which are considered important for proliferation and neuroimmunomodulatory activity. In this study, we compared the effects of SP with those of the novel tachykinin Hemokinin-1 (HK-1) in the human astrocytoma cell line U-251 MG. We show that U-251 MG cells express high levels of Neurokinin-1 (NK-1) receptors. The binding affinities of 125I-SP and 125I-mHK-1 to these receptors were in a similar, subnanomolar range. HK-1 and SP stimulated Ca2+ mobilization and induced increased cytokine mRNA expression. A specific NK-1 receptor antagonist blocked the observed effects. We conclude that there are no qualitative differences in SP and HK-1-evoked responses, suggesting that both peptides act through NK-1 receptors in U-251 MG cells. Moreover, we show TAC4 mRNA expression in gliomas, indicating a possible involvement of HK-1 in glioma biology.
Similar articles
-
Co-regulated decrease of Neurokinin-1 receptor and Hemokinin-1 gene expression in monocytes and macrophages after activation with pro-inflammatory cytokines.J Neuroimmunol. 2007 Jul;187(1-2):83-93. doi: 10.1016/j.jneuroim.2007.04.019. Epub 2007 May 29. J Neuroimmunol. 2007. PMID: 17537522
-
Hemokinin 1 is a full agonist at the substance P receptor.Nat Immunol. 2001 Dec;2(12):1088. doi: 10.1038/ni1201-1088. Nat Immunol. 2001. PMID: 11725292 No abstract available.
-
Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.J Cell Physiol. 2003 Oct;197(1):30-41. doi: 10.1002/jcp.10234. J Cell Physiol. 2003. PMID: 12942538
-
Involvement of substance P and the NK-1 receptor in cancer progression.Peptides. 2013 Oct;48:1-9. doi: 10.1016/j.peptides.2013.07.024. Epub 2013 Aug 7. Peptides. 2013. PMID: 23933301 Review.
-
Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides.Vascul Pharmacol. 2006 Oct;45(4):200-8. doi: 10.1016/j.vph.2005.08.028. Epub 2006 Jul 6. Vascul Pharmacol. 2006. PMID: 16931167 Review.
Cited by
-
Role of tachykinin 1 and 4 gene-derived neuropeptides and the neurokinin 1 receptor in adjuvant-induced chronic arthritis of the mouse.PLoS One. 2013 Apr 23;8(4):e61684. doi: 10.1371/journal.pone.0061684. Print 2013. PLoS One. 2013. PMID: 23626716 Free PMC article.
-
Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).J Biol Chem. 2013 Jan 4;288(1):306-18. doi: 10.1074/jbc.M112.389783. Epub 2012 Nov 19. J Biol Chem. 2013. PMID: 23166329 Free PMC article.
-
The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma.Biomed Res Int. 2022 Apr 4;2022:6291504. doi: 10.1155/2022/6291504. eCollection 2022. Biomed Res Int. 2022. PMID: 35434136 Free PMC article.
-
Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneedle arrays suppresses allergic contact dermatitis.J Allergy Clin Immunol. 2022 Jul;150(1):114-130. doi: 10.1016/j.jaci.2021.12.794. Epub 2022 Jan 24. J Allergy Clin Immunol. 2022. PMID: 35085664 Free PMC article.
-
β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition.J Biol Chem. 2017 May 26;292(21):8933-8947. doi: 10.1074/jbc.M116.770420. Epub 2017 Mar 24. J Biol Chem. 2017. PMID: 28341744 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous